The latest report by IMARC Group, titled "Transfection Reagents and Equipment Market Report by Product (Reagents, Equipment), Technology (Biochemical Based Transfection, Physical Transfection, Viral-Vector Based Transfection), Application (Biomedical Research, Protein Production, Therapeutic Delivery), End User (Pharmaceutical and Biotechnology Companies, Academics and Research Institutes), and Region 2025-2033," finds that the global transfection reagents and equipment market reached a value of USD 1,037 Million in 2024. Transfection reagents and equipment are used to modulate gene expression in eukaryotic cells in vitro and in vivo. They prevent the production of certain proteins by hindering the translation process and allow researchers to generate stable cell lines and introduce deoxyribonucleic acid (DNA) plasmids for expression and small interfering RNA (siRNA). They also provide cost-effective production of recombinant human therapeutic proteins in sufficient quantities. Owing to these properties, transfection reagents and equipment are widely utilized to produce r-proteins, antibodies, and viral vectors for vaccines.
Global Transfection Reagents and Equipment Market Trends:
The market is primarily driven by the recent outbreak of the coronavirus disease (COVID-19) pandemic across the globe. At present, governing agencies of numerous countries are implementing favorable initiatives to accelerate the vaccination drive. Consequently, due to the emergence of newer variants, transfection reagents and equipment are widely utilized to develop innovative strategies or repurpose existing treatments to fight virus infection. In addition, the increasing detection of new cancer variants and the escalating demand for precision medicine and high-quality oncology treatment are accelerating product adoption in cancer research and drug development. This, coupled with the emergence of gene therapies to treat diseases caused by genetic problems, is positively influencing market growth. Moreover, various advancements in transfection technologies and the increasing investments in biotechnology and pharmaceutical sectors are anticipated to augment market growth in the coming years. Looking forward, IMARC Group expects the market to reach USD 1,834 Million by 2033, exhibiting a CAGR of 6.5% during the forecast period (2025-2033).
Market Summary:
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800